CB21 Pharma
@cb21pharma.com
At CB21 Pharma s.r.o., we advance healthcare through scientific innovation. We use natural active pharmaceutical ingredients (APIs) - Dronabinol, Cannabidiol and Cannabis Extract - to develop medical therapies and groundbreaking cosmetic solutions, focusing on non-psychotropic cannabinoids.
CB21 Pharma's Company Logos
CB21 Pharma's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#646464
Dove Gray
100, 100, 100
0, 0, 39
0, 0, 0, 61
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About CB21 Pharma
CB21 Pharma is a pharmaceutical company that specializes in developing and introducing innovative treatments based on the use of non-psychotropic cannabinoids (CBD) with other active ingredients. They are dedicated to providing scientific solutions to help patients by prioritizing research and development of pharmaceutical products containing non-psychotropic cannabinoids. CB21 Pharma aims to be a global leader in this field through evidence-based medicine, developmental processes, and regulatory and manufacturing expertise.
Their focus on benefiting patients drives their research program and achievements. With the utilization of the latest scientific knowledge, preclinical and clinical development, and modern technologies, CB21 Pharma ensures the highest quality of new products for end users. They also develop and sell functional cosmetics for the 21st century, using their own production of API, including natural isolated cannabidiol, synthetic cannabidiol, and extracts from hemp.
CB21 Pharma's team consists of experts in the field, including the CEO and co-founder, Jan Storch, who has a background in organic chemistry, and COO and co-founder, Lenka Průšová, who has expertise in cosmetics. The company's research and development focus on various medical conditions, such as inflammatory disorders, psychiatric disorders, and pain. They collaborate with their scientific board and conduct clinical trials in Czech Republic's academic hospitals to ensure the effectiveness and safety of their products.
In addition to pharmaceutical products, CB21 Pharma also offers a wide range of scientifically-backed cosmetic products that utilize the beneficial properties of cannabidiol. CB21 Pharma's commitment to quality and innovation is evident in their achievements, such as being granted a certificate of quality management and a permit for the production of medicinal substances. They have also obtained certification for the production of medical devices containing cannabidiol, making them the first company in the EU to receive such certification for class IIa medical devices.
With their focus on research, development, and strategic partnerships, CB21 Pharma continues to advance the field of non-psychotropic cannabinoid-based pharmaceutical products and cosmetics to improve the well-being of patients worldwide
